1ISG-008 Optimisation programme of omalizumab treatment for chronic idiopathic urticaria

Autor:	MD Gil-Sierra, MDP Briceño-Casado, C Moreno-Ramos, JC Armario-Hita, JM Borrero-Rubio
Rok vydání:	2022
Zdroj:	Section 1: Introductory statements and governance.
DOI:	10.1136/ejhpharm-2022-eahp.6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::510713529c30a03100bf625590972ca9 https://doi.org/10.1136/ejhpharm-2022-eahp.6 Zobrazit plný text záznamu